Literature DB >> 12960550

Bacterial reduction by cell salvage washing and leukocyte depletion filtration.

Jonathan H Waters1, Marion J Tuohy, Donna F Hobson, Gary Procop.   

Abstract

BACKGROUND: Blood conservation techniques are being increasingly used because of the increased cost and lack of availability of allogeneic blood. Cell salvage offers great blood savings opportunities but is thought to be contraindicated in a number of areas (e.g., blood contaminated with bacteria). Several outcome studies have suggested the safety of this technique in trauma and colorectal surgery, but many practitioners are still hesitant to apply cell salvage in the face of frank bacterial contamination. This study was undertaken to assess the efficacy of bacterial removal when cell salvage was combined with leukocyte depletion filtration.
METHODS: Expired packed erythrocytes were obtained and inoculated with a fixed amount of a stock bacteria (Escherichia coli American Type Culture Collections [ATCC] 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 29213, or Bacteroides fragilis ATCC 25285) in amounts ranging from 2,000 to 4,000 colony forming units/ml. The blood was processed via a cell salvage machine. The washed blood was then filtered using a leukocyte reduction filter. The results for blood taken during each step of processing were compared using a repeated-measures design.
RESULTS: Fifteen units of blood were contaminated with each of the stock bacteria. From the prewash sample to the postfiltration sample, 99.0%, 99.6%, 100%, and 97.6% of E. coli, S. aureus, P. aeruginosa, and B. fragilis were removed, respectively. DISCUSSION: Significant but not complete removal of contaminating bacteria was seen. An increased level of patient safety may be added to cell salvage by including a leukocyte depletion filter when salvaging blood that might be grossly contaminated with bacteria.

Entities:  

Mesh:

Year:  2003        PMID: 12960550     DOI: 10.1097/00000542-200309000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  14 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

Review 3.  Intra-operative cell salvage: a fresh look at the indications and contraindications.

Authors:  Stephen A Esper; Jonathan H Waters
Journal:  Blood Transfus       Date:  2011-01-13       Impact factor: 3.443

Review 4.  [Cell salvage : Scientific evidence, clinical practice and legal framework].

Authors:  T Seyfried; E Hansen
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

Review 5.  Clinical Utility of Autologous Salvaged Blood: a Review.

Authors:  Steven M Frank; Robert A Sikorski; Gerhardt Konig; Diamantis I Tsilimigras; Jan Hartmann; Mark A Popovsky; Timothy M Pawlik; Jonathan H Waters
Journal:  J Gastrointest Surg       Date:  2019-08-29       Impact factor: 3.452

6.  Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.

Authors:  Paolo Feltracco; Marialuisa Brezzi; Stefania Barbieri; Helmut Galligioni; Moira Milevoj; Cristiana Carollo; Carlo Ori
Journal:  World J Hepatol       Date:  2013-01-27

7.  Patient Blood Management: A Patient-Orientated Approach to Blood Replacement with the Goal of Reducing Anemia, Blood Loss and the Need for Blood Transfusion in Elective Surgery.

Authors:  Hans Gombotz
Journal:  Transfus Med Hemother       Date:  2012-03-08       Impact factor: 3.747

8.  A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty.

Authors:  Vidya K Rao; Robert Dyga; Christopher Bartels; Jonathan H Waters
Journal:  Transfusion       Date:  2012-02-17       Impact factor: 3.157

9.  Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.

Authors:  Steven M Frank; Elizabeth C Wick; Amy E Dezern; Paul M Ness; Jack O Wasey; Andrew C Pippa; Elizabeth Dackiw; Linda M S Resar
Journal:  Transfusion       Date:  2014-06-18       Impact factor: 3.157

10.  Cell salvage for postpartum haemorrhage during vaginal delivery: a case series.

Authors:  Grace Lim; Eleni Kotsis; Jamie M Zorn; Patricia L Dalby; Catherine J Ralph; Jonathan H Waters
Journal:  Blood Transfus       Date:  2017-09-29       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.